South Korea vs Tajikistan: Cases started on MDR-TB treatment
South Korea
461
in 2024
Tajikistan
421
in 2024
South Korea rank
31st
Tajikistan rank
34th
Cases started on MDR-TB treatment over time
- South Korea
- Tajikistan
How they compare
South Korea currently reports 461 against 421 in Tajikistan, a difference of 40.
That makes South Korea's figure about 1.1 times Tajikistan's.
The two have swapped places 1 time across 14 shared years of data; in 2011 it was Tajikistan ahead.
South Korea ranks 31st and Tajikistan ranks 34th of 193 countries.
South Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | South Korea | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 835.78 | 630.67 | 205.11 | South Korea |
| 2020s | 562 | 491.4 | 70.6 | South Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, South Korea or Tajikistan?
- South Korea, at 461 against 421 in Tajikistan as of 2024.
- What is the difference in cases started on mdr-tb treatment between South Korea and Tajikistan?
- 40, with South Korea ahead.
- How many years of comparable data are there for South Korea and Tajikistan?
- 14 years are reported by both, from 2011 to 2024.
- How do South Korea and Tajikistan rank globally for cases started on mdr-tb treatment?
- South Korea ranks 31st and Tajikistan ranks 34th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.